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NEWS
Small Conference Grants are Available!
Sally Gore, MS, MSLIS
Research Evaluation Analyst, UMCCTS
(with contributions from Drs. Sherry Pagoto and Ed Boudreaux)
 
The UMass Center for Clinical and Translational Science (UMCCTS) offers Small Conference Grants
(SCG) designed to leverage the convening capacity of the UMCCTS to create new, multidisciplinary teams
to address a pressing health need. The conference can be a symposium, educational program, seminar,
workshop, or any other organized and formal meeting. The goal of the SCG is to facilitate networking
opportunities between faculty that focus on clinical and translational research.
 
One example, the UMass Center for mHealth and Social Media used a SCG to host a 3-day Hackathon to
catalyze mHealth research between UMass researchers and local academic partners. The focus was on
developing novel approaches to tobacco use and obesity, two of the most significant causes of death and
disease burden in the U.S. The Hackathon generated several pilot projects producing data now being
analyzed for publications and grant applications. One of the most interesting things to come out of the
Hackathon was the development of the app, "Slip Buddy." It allows users to hit an "OOPS!" button on their
mobile device whenever they find themselves overeating. The result is that individuals are able to track
patterns associated with this behavior including stress, sleep, time of day, or location. Results of the "Slip
Buddy" pilot have been submitted to a conference, as well as written up for publication.
 
Our Hackathon was fantastic. In fact, we would love to do another. Getting investigators
from vast backgrounds including engineering, computer science, mathematics,
medicine, and behavioral science into one room to discuss a clinical problem led to
novel solutions that none of us could have come up with alone. I now regularly
collaborate with the folks who came and we have several ongoing projects together.
~ Sherry Pagoto, PhD, Hackathon Co-organizer
 
A Small Conference Grant also helped UMass Memorial Health Care and UMass Medical School catalyze
and focus its suicide prevention efforts. Together, the institutions have formed a collaborative effort aimed at
building a systems-based approach to suicide prevention referred to as the System of Safety (SOS). The
first day of the conference was held in July and helped to set the tone for the SOS effort. Outside speakers
from the MA Department of Public Health and the Suicide Prevention Resource Center provided
background and context. Three breakout workgroups followed, focusing on helping to identify the "current
state" for suicide risk screening, management, and prevention across the UMMHC emergency
departments, inpatient units, and primary care practices. Action items were generated that are being
fulfilled by the three workgroups. A future second day is scheduled to review the action item progress,
including reviewing the more detailed "current state" maps. Day 2 will conclude with brainstorming an
"ideal state" and building action items to move from the current to ideal state.
 
The CTSA conference funding has made the SOS better prepared to compete for and receive
extramural funding to support its efforts. It allowed us to bring together our diverse stakeholders,
who are geographically dispersed and who have heretofore only collaborated in "virtual space," to
meet in a common physical space with dedicated time to devote to the effort.
~ Ed Boudreaux, PhD, Conference Organizer
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If you have an idea for an event that a SCG could help fund, visit the UMCCTS website under Funding for
more information and RFA, or contact Nate Hafer, PhD, UMCCTS Director of Operations.
DID YOU KNOW?
Ethical Dilemmas in Scientific Research and
Professional Integrity
The Atlanta Clinical & Translational Science Institute would like to share
their Ethical Dilemmas in Scientific Research and Professional Integrity website, video and podcast with
each CTSA and beyond.
This webpage presents 40+ case scenarios involving responsible conduct in research. Each case is
followed by a brief, expert opinion that suggests strategies for resolution.  These resources have proven
useful as teaching aids and are broadly relevant across the research spectrum.
Ethical Dilemmas in Scientific Research and Professional Integrity Website
Ethics of Authorship in Research Video
Ethics Podcast in Research: Reproducibility
Questions or comments?   Please email Elizabeth Pittman Thompson, Director of Communications,
Atlanta Clinical & Translational Science Institute (ACTSI), Emory University, Atlanta, GA
EVENTS
 August 2016 Events
Human Research Protection Program (HRPP)
Upcoming Educational Opportunities
Clinical Research Professionals Group (CRPG) Meetings:
Friday, August 19, 2016
10:00 - 11:00 am
Hiatt Auditorium, S1-608, UMMS, Worcester
Wednesday, September 14, 2016
12:00 - 1:00 pm
Albert Sherman Center, ASC7-2072-7th floor conference room, UMMS, Worcester
Learn More
HIPAA and Human Subjects Research
Please save the following dates for an exciting panel discussion series on HIPAA and Human Subjects
Research.
Wednesdays, Amphitheater I, S2-102, UMMS, Worcester
November 2, 2016 November 9, 2016
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4:00 - 5:00 pm 8:00 - 9:00 am
November 16, 2016
8:00 - 9:00 am
November 30, 2016
12:00 - 1:00 pm
Research Coordinator Trainings
The Basic and Intermediate Clinical Research Coordinator trainings will not be offered during the summer
months, but stay tuned for upcoming dates in the fall of 2016!
Questions?   Please email HRPEducation@umassmed.edu
Peter Reinhart, PhD
Director, Institute for Applied Life Sciences
Clinical Professor, Biochemistry and Molecular Biology
University of Massachusetts Amherst
"Translating Basic Discoveries into Applied Technologies and
Product Candidates at the Institution for Applied Life Sciences"
Monday, August 29, 2016
11:00 am - 12:00 pm
WEBINAR
This presentation will provide an overview of the newly formed Institute for Applied Life Sciences  (IALS) at
UMass Amherst, and discuss learnings and challenges faced implementing a biotech-like 'team science'
approach within an academic setting.
The Institute seeks to translate life science research into technologies and product candidates that improve
human health. Furthermore, IALS will train an entrepreneurial workforce skilled in the discovery,
development, and manufacture of medical devices, biomolecules, and delivery vehicles for the life
sciences. This vision will be achieved by bringing together faculty from many different departments
working in collaboration with industry partners - requiring a 'team science' approach. IALS is a
multidisciplinary organization spanning numerous colleges and schools, combining the deep expertise
coming from more than 25 departments to fulfill its mission. The Institute, currently consisting of more than
150 UMass faculty members, is organized into three Centers:
Center for Bioactive Delivery (CBD),seeks to deliver the right drug to the right place. This is
achieved by creating novel delivery technologies for small and large molecules. These technologies
are then optimized to deliver compounds to specific organs as unique biomolecule/vehicle pairs.
Models to Medicine Center (M2M), will identify novel drug targets and therapeutic strategies by
leveraging mechanistic insights from molecular pathways implicated in cell health and disease.
These insights will provide the next generation of therapeutics for a range of diseases with huge
unmet patient needs.  
Center for Personalized Health Monitoring (CPHM), seeks to be a world-leading research,
partnership, and demonstration facility for accelerating the commercialization of low-cost, multi-
function, autonomous, intelligent sensor systems for personalized health care and biometric
monitoring. These sensors, and the data they generate, will keep people healthier and contribute to
establishing the efficacy of new therapeutics.
IALS is product-focused, interdisciplinary, collaborative, outward-looking, and entrepreneurial. 
Register now for this educational and informative webinar!
For past UMCCTS Team Science Webinar Series presentations - please click here. 3
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Healthcare Delivery Institute (HDI) presents
The Digital Health and IoT Journey
On the Road to Personalized Medicine and Better Health
Monday, September 12, 2016
8:15 am - 3:00 pm
Worcester Polytechnic Institute
Rubin Campus Center
100 Institute Road, Worcester, MA 01609
The program will consist of speaker presentations, interactive panels, and lunchtime networking with
demos, posters, and exhibitor areas. We invite technology companies, investors, and other organizations
focused on innovation in the healthcare industry to sponsor the forum and/or demo your product/technology.
Please contact wpihdi@wpi.edu for more information about sponsorship or demo space.
Register today!
Robert Hindes, MD
Chief Medical Officer and Co-Founder, TREK Therapeutics, PBC
Pharma experience includes, BMS, Pharmassett, BeyondWest Pharma
Clinical Trials: It Doesn't Need to be the "Same Old, Same Old"
Wednesday, September 21, 2016
Faculty Conference Room, S1-342
University of Massachusetts Medical School
4:00-5:00 pm - Lecture and Case Study
5:00-5:30 pm - Networking (refreshments served)
Lecture and Case Study:  This lecture will describe the familiar pre IND>>IND>>ph1>>ph2>>ph3>> NDA
route for drug development in the U.S. The system is famous for being formulaic and slow to respond to
new developments. Difficult questions will be discussed including whether placebo controlled studies are
ethical, who should take the risk in compassionate access programs for desperate treatments seeking
access to unapproved drugs and issues related to study size, market size and biomarkers. Dr. Hindes will
describe examples where the FDA changed their approach in response to data and public pressure.
This event will be a great opportunity for networking and collaboration too!
Register today!
Upcoming MassTERi Education Seminars:
10/20/16
Pharmaceutical Innovation: Why Do Innovative Drugs "Die" Along the Way?
11/17/16
Structure Activity Relationship (SAR): Moving the Goal Posts
The UMass Center for mHealth and Social Media invites you to
attend the webinar, hosted by the Mayo Clinic and Vanderbilt
University Medical Center, 
"The New Social Media Playbook" 4
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Shaw Building
419 Belmont Street, 2nd floor conference room #1
Worcester, MA 01605
Due to popular demand, Lee Aase, Director, Center for Social Media, Mayo Clinic and Cynthia
Floyd Manley, Director, Content Strategy, Vanderbilt University Medical Center, are back to
discuss which key platforms are still making an impact, leveraging social technologies to improve patient
experience and drive engagement, optimizing your resources to ensure consistent brand messaging, and
reviewing the platforms of the future-and which are on the way out.
Please RSVP by 9/14/16 as space is limited.  This webinar will be a streaming live event.
The Diabetes Innovation Challenge
Semi-Finalist Presentations
Please join us for The Diabetes Innovation Challenge qualified
semi-finalist translational project presentations.
Thursday, September 29, 2016
4:00 pm
Albert Sherman Center Auditorium (2nd floor), UMMS, Worcester
The Diabetes Innovation Challenge is brought to you by the T1D Exchange and the Massachusetts
Medical Device Development Center (M2D2) at UMass.  The Challenge offers medical device and biotech
entrepreneurs the chance to win in-kind awards and receive critical early and later-stage validation of their
ideas and products specific to Type 1 and Type 2 diabetes.  The Diabetes Innovation Challenge is a
proposal- and presentation-based competition for small companies in the T1 and T2 space that are making
real progress towards better outcomes for those diagnosed.
Read More
   Register today!
Harvard Catalyst Education Program
Using Metabolomics Data in Network Medicine
November 14, 2016
Sheraton Commander Hotel, Cambridge, MA
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Harvard Catalyst is now accepting applications for Using Metabolomics Data in Network Medicine, a one-
day module that will focus on metabolomics data and the analytical challenges this type of data presents.
Applications close: Friday, September 16, 2016
Read More
FUNDING and TRAINING OPPORTUNITIES
World Without Disease QuickFire Challenges
Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc., are looking for
the best idea, technology or solution to award $500,000. The JLABS QuickFire
Challenges are competitions designed to attract game-changing, early-stage
innovation in the therapeutics, consumer, health technologies and medical device
sectors.
Winners will be awarded a variety of prizes (including cash and/or lab space),
benefit from world-class lab facilities, be supported by an onsite team and have access to a global network
of industry experts and programming.
Deadline to apply: Wednesday, August 31, 2016
Learn More
PCORI - Pragmatic Clinical Studies to Evaluate Patient-
Centered Outcomes - Cycle 3 2016
PCORI seeks to fund pragmatic clinical trials, large simple trials, or large-scale
observational studies that compare two or more alternatives for addressing
6
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prevention, diagnosis, treatment, or management of a disease or symptom;
improving healthcare system-level approaches to managing care; communicating or disseminating
research results to patients, caregivers, or clinicians; or eliminating health or healthcare disparities.
Proposed studies must address critical clinical choices faced by patients, their caregivers, clinicians, or
delivery systems. They must involve broadly representative patient populations and be large enough to
provide precise estimates of hypothesized effectiveness differences and to support evaluation of potential
differences in treatment effectiveness in patient subgroups.
Letter of Intent (LOI) Deadline: Wednesday, September 14, 2016
Learn More
The Alfred P. Sloan Foundation
Sloan Research Fellowships
The Alfred P. Sloan Foundation is now accepting nominations for Sloan Research Fellowships in eight
fields: chemistry, computational and evolutionary molecular biology, computer science, economics,
mathematics, neuroscience, ocean sciences, and physics.
These two-year, $60,000 fellowships are awarded annually to 126 early-career faculty in recognition
of their distinguished performance and exceptional potential as researchers.
Nominations and other supporting material are due online: Thursday, September 15, 2016.
Read More
Charles H. Hood Foundation
Child Health Research Awards Program
The intent of the Award is to support newly independent faculty, provide the opportunity to demonstrate
creativity, and assist in the transition to other sources of research funding.  Research projects must be
relevant to child health.
Deadline date: Monday September 19, 2016
Learn More
Pfizer's Centers for Therapeutic Innovation (CTI)
Fall 2016 Call for Proposals
Pfizer's CTI is a unique program that collaborates with leading academic
medical centers (i.e. UMass), the NIH, and foundations to speed the translation
of novel targets to the clinic.
Pfizer's CTI is now accepting proposal applications for the following:
Biotherapeutic and Small-Molecule Targets
Alzheimer's Disease
Lupus and Immunometabolism
Crohn's and Colitis Disease
Pre-Proposal Deadline: Friday, October 7, 2016
Pfizer's Centers for Therapeutic Innovation (CTI) and
the Jeffrey Modell Foundation (JMF)
Call for Proposals - Fall 2016
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Pfizer's CTI and the JMF seek to identify and fund novel research projects that have the potential to benefit
patients with Primary Immunodeficiency.  Pfizer's CTI and JMF will jointly sponsor and fund ($150,000
- $250,000) selected, novel research projects that increase understanding of immune regulatory pathways
with potential implications for Primary Immunodeficiency.
Submission Deadline: Friday, October 7, 2016
Learn More
National Science Foundation
2017 Alan T. Waterman Award
The National Science Foundation (NSF) is pleased to accept
nominations for the 2017 Alan T. Waterman Award. Each year, the Foundation bestows the Waterman
Award in recognition of the talent, creativity, and influence of a singular young researcher.
Nominees are accepted from all sources, and from any field of science and engineering that NSF supports.
The award recipient will receive a medal and an invitation to the formal awards ceremony in Washington,
DC. In addition, the recipient will receive a grant of $1,000,000 over a five-year period  for scientific
research or advanced study in any field of science or engineering supported by NSF, at any institution of
the recipient's choice. We are especially interested in nominations for women, members of
underrepresented groups in science and engineering, and persons with disabilities.
Application packets are due by Friday, October 21, 2016.
Read More
NIH Science of Behavior Change:
Use-inspired Basic Research to Optimize
Behavior Change Interventions and
Outcomes PA-16-334
The goal of this funding opportunity announcement is
to test how and why behavior change interventions
produce and sustain desired outcomes when
implemented in experimental, clinical, community or
population-level settings.
Please contact Nate Hafer if interested in applying.
Deadline date: November 10, 2016
Learn More
NIH Limited Competition:
Exploratory CTSA Collaborative
Innovation Awards (R21) PAR-16-343
The purpose of this funding opportunity
announcement is to support highly innovative,
exploratory, collaborative research projects in the
NCATS' Clinical and Translational Science Award
(CTSA) program, with the goal of assessing utility
and feasibility of proposed innovation(s).
Please contact Nate Hafer if interested in applying.
Deadline date: Rolling deadlines
Learn More
NIH Limited Competition:
Administrative Supplements to Enhance Network Capacity: Collaborative
Opportunities for the CTSA Program (Admin Supp) PA-16-328
NCATS announces the availability of funds for Administrative Supplements to enhance network capacity in
the Clinical and Translational Sciences Awards (CTSA) program.  These funds are intended to enhance
network capacity through implementing, assessing, and/or disseminating discoveries in methods,
approaches, education, and training in clinical and translational science.  Funds will allow investigators
from two or more different CTSA hubs to form collaborations within the CTSA network and/or with external
partners to implement, assess, and/or disseminate discoveries from across the network.  These activities
8
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must be within the scope of the approval aims of the parent award and provide significant advances across
the translational science spectrum.
Please contact Nate Hafer if interested in applying.
Deadline date: Rolling deadlines
Learn More
University of Massachusetts Medical School
Transdisciplinary Training in 
Cardiovascular Research (T32)
UMass has a cardiovascular T32 training grant entitled "Transdisciplinary
Training in Cardiovascular Research" under the direction and senior
leadership of Drs. Catarina Kiefe and John Keaney.  The program represents a
wonderful opportunity for the institution to promote the entire spectrum (T0-T2+) of cardiovascular research
on our campus.  We are writing to request applications from trainees who wish to become part of this
exciting program at the postdoctoral level. New trainees will join 4 other current trainees in the program.
Eligibility:  Please see http://grants.nih.gov/grants/guide/pa-files/PA-14-015.html
Duration of support: Funding for two years of support provided.  Trainees may apply for an additional
year.
 
Amount of support: Based upon the NIH stipend schedule as outlined in the link below.  Faculty
sponsors may, at their discretion and with department and institutional approval supplement the NIH
stipend, but only from a non-federal, non-sponsored funding source.
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-048.html
Proposals are accepted on a rolling basis.
Learn More
Please remember to cite the CTSA Grant # UL1-TR001453 in all supported journal
publications.
The UMass Center for Clinical and Translational Science (UMCCTS) was founded in 2006 to enhance clinical and
translational research across the five University of Massachusetts campuses and our clinical partner, UMass Memorial
Health Care. With the receipt of an NIH Clinical and Translational Science Award (CTSA) in 2010, and its successful
renewal in 2015, the UMCCTS joined a network of 62 NIH-funded centers collaborating to transform the conduct of clinical
and translational research across the U.S. Other key partners include our patients and communities, foundations,
biotechnology and pharmaceutical companies, and members of the venture capital and philanthropic communities.
We encourage you to browse through our website to learn more about how the UMCCTS catalyzes clinical and
translational research through education and training, pilot funding programs, cores, services and collaboration.
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